Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Waste Manag ; 153: 138-146, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36088861

ABSTRACT

Food waste prevention across the food supply chain has been addressed by the European Union (EU) as the top priority to reduce farm-to-fork impacts. Despite the environmental benefits of food waste prevention are widely acknowledged, life cycle assessments usually do not account for rebound effects, the inclusion of which may decrease or even cancel out the expected environmental savings. Rebound effects are understood as the re-spending of accrued monetary savings, determined by the implementation of food waste prevention initiatives, either on the same product (i.e. direct effects - food) or on other products and/or services (i.e. indirect - non-food) including economy-wide effects (macroeconomic rebound effects). Macroeconomic rebound effects were quantified by means of the global equilibrium model Fidelio and were then converted into environmental impacts by performing an environmentally extended input-output analysis based on the assessment method Environmental Footprint 3.0. From an environmental and an economic perspective, it was found that food waste prevention initiatives across the entire food supply chain were beneficial, but efforts targeting households should be prioritised as the largest potential savings were obtained at this stage. Prevention initiatives implemented at households were associated with potential savings of up to 1 t CO2-eq. t-1, which was reduced to a potential saving of 0.6 t CO2-eq. t-1, corresponding to a 38 % decrease, when accounting for macroeconomic rebound effects. Finally, our results highlighted the importance of accounting for adjustment costs in the production stages of the food supply chain.


Subject(s)
Refuse Disposal , Waste Management , Carbon Dioxide , Environment , Food
2.
Res Vet Sci ; 132: 243-249, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32645514

ABSTRACT

The objective of this retrospective cohort study was to determine the impact of a recent trauma on thyroid axis and adrenal activity in dogs and to assess the usefulness of urinary cortisol-to-creatinine ratio (UCCR), basal serum thyroid-stimulating hormone (TSH), total thyroxine (tT4), and free thyroxine (fT4) concentrations in predicting outcome in dogs traumatized by a road traffic accident (RTA). An RTA exposed group of 210 dogs was evaluated within 24  hours of the trauma. Their data were compared with data from a matched group of dogs with other diagnoses. UCCR was positively correlated with the trauma severity and was higher in the exposed group than in the nonexposed group (median 101.500 vs. 21.02; p < 0.0001). tT4 values were statistically similar between the two groups, but were correlated with a trauma score, while TSH (median = 0.050 vs. 0.080 ng/mL; p < 0.0001) and fT4 (median = 15.850 vs. 17.950 pmol/L; p = 0.0037) were significantly lower for the exposed group. Nonsurvivors in comparison to survivors presented and higher median UCCR (181.800 vs. 93.850 respectively; p = 0.020), and a lower serum fT4 (12.700 vs. 16.500 pmol/L, respectively; p = 0.0046). A similar pattern had been observed for tT4. TSH levels were not predictive of survival. This study provides insights into the endocrine characteristics of dogs suffering from acute trauma. UCCR was higher while fT4 and TSH were both lower in RTA-injured dogs than in dogs affected by other conditions. Furthermore low fT4 and tT4, and a high UCCR could be useful prognostic factors in dogs affected by RTA trauma.


Subject(s)
Accidents, Traffic , Thyroid Gland/physiology , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood , Animals , Cohort Studies , Dogs , Female , Humans , Kidney Function Tests , Male , Retrospective Studies
3.
Vet Sci ; 7(2)2020 Apr 12.
Article in English | MEDLINE | ID: mdl-32290621

ABSTRACT

In this study, we describe the computed tomography (CT) features of pulmonary laceration in a study population, which included 364 client-owned dogs that underwent CT examination for thoracic trauma, and compared the characteristics and outcomes of dogs with and without CT evidence of pulmonary laceration. Lung laceration occurred in 46/364 dogs with thoracic trauma (prevalence 12.6%). Dogs with lung laceration were significantly younger than dogs in the control group (median 42 months (interquartile range (IQR) 52.3) and 62 months (IQR 86.1), respectively; p = 0.02). Dogs with lung laceration were significantly heavier than dogs without laceration (median 20.8 kg (IQR 23.3) and median 8.7 kg (IQR 12.4 kg), respectively p < 0.0001). When comparing groups of dogs with thoracic trauma with and without lung laceration, the frequency of high-energy motor vehicle accident trauma was more elevated in dogs with lung laceration than in the control group. No significant differences were observed between groups regarding tge frequency and length of hospitalization and 30-day mortality. Similar to the human classification scheme, four CT patterns are described in dogs in this study: Type 1, large pulmonary laceration located deeply in the pulmonary parenchyma or around an interlobar fissure; Type 2, laceration occurring in the paraspinal lung parenchyma, not associated with vertebral fracture; Type 3, subpleural lung laceration intimately associated with an adjacent rib or vertebral fracture; Type 4, subpleural lesions not associated with rib fractures. Complications were seen in 2/46 dogs and included lung abscess and collapse.

4.
Res Vet Sci ; 124: 357-365, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31063900

ABSTRACT

CT attenuation value can help to differentiate exudate from transudate in people. The aim of this cross-sectional study was to assess the utility of CT in characterizing pleural effusions based on attenuation values in a population of dogs having CT and diagnostic thoracentesis within 48 h of each other. The CT attenuation values were determined using four circular, same size, regions of interest (ROIs) placed on the same CT slice with the greatest quantity of fluid. Values of each ROI were recorded and the mean of the four ROIs mean values (mean of the means) was calculated and considered as the CT attenuation value of that patient. The final population included 23 proper inflammatory exudates, 15 chylous effusions, 12 hemorrhagic effusions and 8 transudates. The median of 'mean of the means' values were: exudate 19.22 HU (8.23 to 37.66 HU); chylous effusion 10.26 HU (-0.90 to 15.37); hemorrhagic effusion 31.65 HU (18.10 to 54.97), and transudate 11.20 HU, (-2.52 to 16.59). CT accurately differentiated hemorrhagic from chylous effusion (AUC 1.0, P < 0.0001) and hemorrhagic effusion from transudate (AUC 1.0, P < 0.0001); CT-values allowed good accuracy in distinguishing exudates from transudates [AUC 0.87 (95%, CI: 0.74-1.0; P < 0.0001)]. HU attenuation values did not accurately differentiate between transudates and chylous effusion. A cutoff value of 34.68 HU (sensitivity of 96% and specificity of 95%) discriminated between exudates and hemorrhagic effusions. CT-value <12.15 HU had a sensitivity of 94% and specificity of 78% for identify transudate or chylous effusion.


Subject(s)
Dog Diseases/diagnostic imaging , Pleural Effusion/veterinary , Radiography, Thoracic/veterinary , Tomography, X-Ray Computed/veterinary , Animals , Cross-Sectional Studies , Dogs , Exudates and Transudates/diagnostic imaging , Female , Male , Pleural Effusion/diagnostic imaging , Pleural Effusion/physiopathology , Radiography, Thoracic/methods , Sensitivity and Specificity , Tomography, X-Ray Computed/methods
5.
J Am Vet Med Assoc ; 253(2): 188-195, 2018 Jul 15.
Article in English | MEDLINE | ID: mdl-29963955

ABSTRACT

OBJECTIVE To determine survival estimates and outcome predictors for shelter cats with feline panleukopenia virus (FPV) infection. DESIGN Retrospective cohort study. ANIMALS 177 shelter cats with FPV infection. PROCEDURES Medical records of cats treated for FPV infection from 2011 through 2013 were reviewed to collect information pertaining to signalment; history; results of physical examination, CBC, serum biochemical analysis, and blood gas analysis; and treatments (antimicrobials, antiparasitics, antivirals, antiemetics, analgesics, crystalloid or colloid solutions, and blood products). Survival time and outcome predictors were determined by means of Kaplan-Meier estimation, logistic regression, and mixed-model ANOVA. RESULTS Median survival time after hospital admission was 3 days; 20.3% (36/177) of cats survived to discharge from the hospital. Risk of nonsurvival was greater in cats with (vs without) signs of lethargy, rectal temperature < 37.9°C (I00.2°F), or low body weight at hospital admission. Lower (vs higher) leukocyte count on days 3,4, and 7 of hospitalization, but not at admission, was associated with nonsurvival. Amoxicillin-clavulanic acid, antiparasitics, and maropitant but not interferon-ω were associated with survival, whereas glucose infusion was associated with nonsurvival. CONCLUSIONS AND CLINICAL RELEVANCE Results suggested that FPV infection carried a poor prognosis for shelter cats. Several variables measured at admission or during hospitalization were associated with outcome. Remarkably and contrary to the existing literature, leukopenia at admission had no association with outcome, possibly owing to early prevention of complications.


Subject(s)
Animal Welfare , Disease Outbreaks/veterinary , Feline Panleukopenia Virus/isolation & purification , Feline Panleukopenia/epidemiology , Animals , Cats , Cohort Studies , Feline Panleukopenia/etiology , Feline Panleukopenia/mortality , Female , Italy/epidemiology , Male , Prognosis , Retrospective Studies , Risk Factors , Survival Analysis
6.
JFMS Open Rep ; 3(1): 2055116917714881, 2017.
Article in English | MEDLINE | ID: mdl-28680699

ABSTRACT

CASE SUMMARY: An 11-year-old female spayed domestic shorthair cat was presented with haematuria of 2 months' duration followed by pollakiuria and stranguria. A firm, non-painful mass in the urinary bladder was palpated. Abdominal radiographs and ultrasound were suggestive of a urinary neoplasia. During explorative laparotomy, a partial cystectomy and surgical debulking were performed. Histopathology and immunostaining were consistent with a fibrosarcoma. The cat was discharged 10 days after surgery with a residual mass of about 1.8 cm on ultrasound re-examination. The cat was not given adjuvant therapy. The cat was euthanased 8 months after surgery because of tumour invasion of the urinary trigone and subsequent ureter dilation, hydronephrosis and severe azotaemia. RELEVANCE AND NOVEL INFORMATION: Malignant urinary fibrosarcoma in this cat appeared to be only locally invasive. Palliative surgery without adjuvant postoperative chemotherapy in this cat resulted in an 8 month period of good quality of life.

7.
Can Vet J ; 55(12): 1186-91, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25477548

ABSTRACT

Spontaneous pneumopericardium is a rare condition consisting of pericardial gas in the absence of iatrogenic or traumatic causes; it has been described secondary to pneumonia, lung abscess, and bronchopulmonary disease. This report describes a case of spontaneous pneumopericardium in a dog presenting with dyspnea secondary to pyopneumothorax complicating a bronchopulmonary disease.


Pneumopéricarde spontané chez un chien avec une maladie broncho-pulmonaire compliquée par la pleurésie et le pneumothorax. Un pneumopéricarde spontané est une rare affection qui cause des gaz péricardiques en l'absence de causes iatrogéniques ou traumatiques; il a été décrit comme secondaire à la pneumonie, à un abcès pulmonaire et à la maladie broncho-pulmonaire. Ce rapport décrit un cas de pneumopéricarde spontané chez un chien présenté avec une dyspnée secondaire au pyopneumothorax compliquant une maladie broncho-pulmonaire.(Traduit par Isabelle Vallières).


Subject(s)
Dog Diseases/diagnosis , Pneumopericardium/veterinary , Pneumothorax/veterinary , Animals , Dog Diseases/diagnostic imaging , Dog Diseases/therapy , Dogs , Male , Pericardiocentesis/veterinary , Pleural Effusion/etiology , Pleural Effusion/veterinary , Pneumopericardium/complications , Pneumopericardium/diagnostic imaging , Pneumothorax/diagnostic imaging , Pneumothorax/etiology , Tomography, X-Ray Computed/veterinary
8.
Cancer Lett ; 297(1): 65-74, 2010 Nov 01.
Article in English | MEDLINE | ID: mdl-20510503

ABSTRACT

Nuclear retinoid X receptors (RXRs) and peroxisome proliferator-activated receptors (PPARs are potential candidates as drug target for cancer prevention and treatment. We investigated if the rexinoid 6-OH-11-O-hydroxyphenantrene (IIF) potentiates the antitumoral properties of PPARgamma ligands as ciglitazone and pioglitazone, on two colon cancer cell lines: HCA-7 and HCT-116. Drugs inhibited cell growth and induced apoptosis synergistically. The combination resulted in a decrease of cyclooxigenase-2, metalloproteinases-2 and -9 expression level and activity while PPARgamma, RXRgamma and tissue inhibitors of metalloproteinase-1 and -2 expression were increased. Finally, IIF potentiated PPAR transcriptional activity by enhancement of peroxisome proliferator response elements transactivation.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Cell Movement/drug effects , Cell Proliferation/drug effects , Colonic Neoplasms/pathology , PPAR gamma/agonists , Retinoid X Receptor gamma/agonists , Apoptosis/drug effects , Cell Survival/drug effects , Colonic Neoplasms/genetics , Colonic Neoplasms/metabolism , Cyclooxygenase 2/metabolism , Dose-Response Relationship, Drug , Drug Synergism , HCT116 Cells , Humans , Ligands , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Neoplasm Invasiveness , PPAR gamma/genetics , PPAR gamma/metabolism , Pioglitazone , Response Elements/drug effects , Retinoid X Receptor gamma/metabolism , Thiazolidinediones/pharmacology , Tissue Inhibitor of Metalloproteinase-1/metabolism , Tissue Inhibitor of Metalloproteinase-2/metabolism , Transcriptional Activation/drug effects , Tretinoin/analogs & derivatives , Tretinoin/pharmacology
9.
Anticancer Res ; 30(2): 535-40, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20332466

ABSTRACT

Valproic acid (VPA) is an established drug in the long-term therapy of epilepsy. Recently, VPA has demonstrated antitumor activity as a histone deacetylase (HDAC) inhibitor. In this study, the anticancer properties of VPA on neural crest-derived human tumor cell lines G361 melanoma, U87MG glioblastoma and SKNMC Askin tumor cells were investigated. The effect of VPA on cell growth, apoptotic activity and invasive ability were evaluated. Firstly, VPA induced cell growth inhibition and apoptotic activity, as demonstrated by sulforhodamine B protein assay, annexin V assay and by Western blot analysis for Bcl2 and Bax expression levels, in all three cell lines. In addition, VPA led to a decrease of HDAC-1 protein level, as assessed by Western blot analysis. Treatment with VPA caused a decrease in the invasive ability of all three cell lines. Since the invasion process involves a complex system of tightly regulated proteases, matrix metalloproteinases (MMPs) and their tissue-specific inhibitors (TIMPs), the effect of VPA on MMP and TIMP expressions was analysed. Exposure to VPA resulted in a decrease of MMP2 and MMP9 activity and expression level, as assesssed by gelatin zymography and Western blot analysis. In addition, exposure to VPA led to enhanced expression of TIMP1, as assessed by Western blot. Taken together, our results, besides providing further evidence that VPA may represent a promising therapeutic strategy in cancer treatment, may help in the design of new protocols geared at the treatment of neural crest-derived tumors.


Subject(s)
Anticonvulsants/pharmacology , Brain Neoplasms/drug therapy , Glioblastoma/drug therapy , Melanoma/drug therapy , Thoracic Neoplasms/drug therapy , Valproic Acid/pharmacology , Apoptosis/drug effects , Blotting, Western , Brain Neoplasms/genetics , Brain Neoplasms/pathology , Cell Line, Tumor , Cell Proliferation/drug effects , Glioblastoma/genetics , Glioblastoma/pathology , Humans , Matrix Metalloproteinases/metabolism , Melanoma/genetics , Melanoma/pathology , Neoplasm Invasiveness , Thoracic Neoplasms/genetics , Thoracic Neoplasms/pathology , Tissue Inhibitor of Metalloproteinase-1/metabolism
10.
Article in English | MEDLINE | ID: mdl-19857991

ABSTRACT

The development of non-invasive methodologies and portable instrumentation for in situ studies has been subject to great research and development in recent years in the field of conservation science. Despite such interest, very few reported studies employ these versatile techniques in the monitoring of cleaning treatments. This paper describes the application of mid-FTIR fibre-optic reflectance spectroscopy to monitor and evaluate the cleaning treatment of an oil painting using the chelating agent, triammonium citrate, a task undertaken in close collaboration with the painting conservator. Results obtained on site verify the removal of calcium oxalate and an organic component from the surface of the painting, later identified as a terpenic varnish. The subsequent, in laboratory FTIR and GC-MS analysis of the cotton swabs employed during the cleaning treatment acts as an additional non-invasive manner to support the results obtained in situ by mid-FTIR spectroscopy and to better understand the mechanism of the chosen cleaning agent.


Subject(s)
Fiber Optic Technology/methods , Gas Chromatography-Mass Spectrometry/methods , Paintings , Ferrocyanides/chemistry , Online Systems , Paint/analysis , Solvents/chemistry , Spectroscopy, Fourier Transform Infrared
11.
Oncol Rep ; 13(6): 1139-44, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15870934

ABSTRACT

Histone acetyltransferase and histone deacetylase (HDAC) determine the acetylation status of histones, and thereby control the regulation of gene expression. HDAC inhibitors have been found to inhibit the growth of a variety of tumor cells in vitro and in vivo. We demonstrated previously that the short-chain fatty acid compound butyrate and its derivative tributyrin (both HDAC inhibitors) arrest cell growth and induce differentiation in human neuroblastoma (NB) cells. In the current study we investigated the effect of the HDAC inhibitor valproic acid (VPA) on proliferation and differentiation in human NB cells (SJ-N-KP, AF8). Treatment with VPA resulted in a strong inhibition of cell proliferation and induction of cell differentiation, as revealed by neurite outgrowth and increase of acetylcholinesterase specific activity. Moreover, we addressed the question of whether the cyclin-dependent kinase inhibitors p21(Cip1) and p27(Kip1) are involved in the mechanism of action of members of the short-chain fatty acids class (VPA, sodium butyrate and tributyrin) of HDAC inhibitors, in human NB cells. We demonstrated that p21(Cip1) is a common target of induction of transcription and protein expression for all the three compounds, while only VPA induced a concomitant increase of p27(Kip1) gene expression. These results suggest that p21(Cip1) could be involved in the inhibition of proliferation and induction of differentiation in human NB cells induced by treatment with VPA or tributyrin or sodium butyrate. Moreover, p21(Cip1) could be applied in the molecular monitoring of drug action in the possible therapeutic application of these short-chain fatty acid members of HDAC inhibitors for human NB treatment.


Subject(s)
Cell Cycle Proteins/metabolism , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Enzyme Inhibitors/pharmacology , Gene Expression Regulation/drug effects , Histone Deacetylase Inhibitors , Neuroblastoma/drug therapy , Acetylation , Acetylcholinesterase/metabolism , Butyrates/pharmacology , Carrier Proteins/metabolism , Cyclin-Dependent Kinase Inhibitor p21 , Cyclin-Dependent Kinase Inhibitor p27 , Fatty Acids/pharmacology , Histone Deacetylases/metabolism , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Neurites/drug effects , Neurites/metabolism , Neuroblastoma/metabolism , Neuroblastoma/pathology , Triglycerides/pharmacology , Tumor Cells, Cultured , Valproic Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...